See every side of every news story

Published 2 days ago • loading... • Updated 2 days ago

Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock

Summary by The Billings Gazette

SAN DIEGO, Sept. 11, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced the pricing of its upsized underwritten public offering of…

24 Articles

24 Articles

+23 Reposted by 23 other sources

Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock

SAN DIEGO, Sept. 11, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced the pricing of its upsized underwritten public offering of…

2 days ago·Tucson, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources24

Leaning Left1Leaning Right0Center11Last Updated16 hours agoBias Distribution

92% Center

Bias Distribution

92% of the sources are Center

92% Center

+6

Untracked bias

+3

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Billings Gazette broke the news in Billings, United States 2 days ago on Thursday, September 11, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics